Market Herald logo


Be the first with the news that moves the market
  • Pure Global Cannabis (TSXV:PURE) has appointed Scott Langille as the company’s new Chief Financial Officer
  • Mr. Langille will replace previous CFO, Bhupender Gosain, effective immediately
  • Mr. Langille has a wealth of experience in the pharmaceutical and cannabis industry with a range of companies
  • Shares in Pure Global Cannabis are currently trading at 7 cents, with a market cap of C$10.33 million

Pure Global Cannabis (TSXV:PURE) has appointed Scott Langille as its new Chief Financial Officer.

The company is a producer of both branded and white label CBD products, operating via its wholly owned subsidiary, PureSinse.

Mr. Langille will replace Pure Global’s previous CFO, Bhupender Gosain, effective immediately.

According to the announcement, Mr. Gosain was also acting as Corporate Secretary and has left to pursue other opportunities.

Mr. Langille brings a wealth of experience, having most recently served as CFO of Wayland Group – another vertically integrated cannabis operator.

He has also served in CFO roles at Tribute Pharmaceuticals and Virexx Medical, leading several financings in both the pharmaceutical and cannabis industries.

A Certified Management Accountant, Mr. Langille holds an MBA from the University of Toronto and an undergraduate Bachelor of Applied Arts degree from Ryerson University.

“We are excited to have Scott join Pure Global.” said Pure Global CEO, Malay Panchal.

“We believe his deep pharma and cannabis industry knowledge and the experience he has gained makes him an ideal choice to lead our financial strategy.”

Mr. Panchal also made reference to several major financings which, once finalised, are expected to strengthen the company’s balance sheet and ensure short-term liquidity.

“Adding Scott’s extensive skillset strengthens our finance organization and complements our management team as we focus on profitability and building shareholder value,” he continued.

Shares in Pure Global Cannabis are currently trading at 7 cents, with a market cap of C$10.33 million.

More From The Market Herald

" Innocan Pharma (CSE:INNO) reports successful efficacy test for vaginal derma product

Innocan Pharma (INNO) has announced successful results from a controlled efficacy test of its vaginal derma product.

" VIVO Cannabis (TSX:VIVO) cleared to be acquired by MediPharm (TSX:LABS)

VIVO (VIVO) has been approved by the Ontario Superior Court of Justice to be acquired by MediPharm.

" The Market Herald’s Weekly Cannabis Report – Mar 24, 2023

HEXO Corp. (TSX:HEXO) slid 2.0 per cent since a sobering report about its place in the cannabis industry.

" Ascend Wellness (CSE:AAWH.U) expands Michigan presence

Ascend (AAWH.U) has announced the opening of its eighth dispensary in Michigan, located in Grand Rapids.